EKER, N. Et Al. 2022. Outcomes of Osteosarcoma in Children Without High-Dose Methotrexate: Could It Be Less Toxic Without Effecting Survival Rates?. JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY , vol.11 , 252-258.

EKER, N., TOKUÇ, A. G., YILMAZ, B., Aktas, Z., BUĞDAYCI, O., EROL, B., ... Senay, E.(2022). Outcomes of Osteosarcoma in Children Without High-Dose Methotrexate: Could It Be Less Toxic Without Effecting Survival Rates?. JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY , vol.11, 252-258.

EKER, NURŞAH Et Al. "Outcomes of Osteosarcoma in Children Without High-Dose Methotrexate: Could It Be Less Toxic Without Effecting Survival Rates?," JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY , vol.11, 252-258, 2022

EKER, NURŞAH Et Al. "Outcomes of Osteosarcoma in Children Without High-Dose Methotrexate: Could It Be Less Toxic Without Effecting Survival Rates?." JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY , vol.11, pp.252-258, 2022

EKER, N. Et Al. (2022) . "Outcomes of Osteosarcoma in Children Without High-Dose Methotrexate: Could It Be Less Toxic Without Effecting Survival Rates?." JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY , vol.11, pp.252-258.

@article{article, author={NURŞAH EKER Et Al. }, title={Outcomes of Osteosarcoma in Children Without High-Dose Methotrexate: Could It Be Less Toxic Without Effecting Survival Rates?}, journal={JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY}, year=2022, pages={252-258} }